Cover Image
Market Research Report
Product code 
1062941

Rituximab Biosimilars Global Market Report 2022

Published: Pre-Order | The Business Research Company | 400 Pages | Delivery time: 2-10 business days

Price

Back to Top
Rituximab Biosimilars Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 400 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Rituximab Biosimilars Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global rituximab biosimilars market.

This report focuses on rituximab biosimilars market which is experiencing strong growth. The report gives a guide to the rituximab biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the rituximab biosimilars? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Rituximab Biosimilars market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider rituximab biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The rituximab biosimilars market section of the report gives context. It compares the rituximab biosimilars market with other segments of the rituximab biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, rituximab biosimilars indicators comparison.

Scope

Markets Covered:

1) By Application: Non-Hodgkin's Lymphoma; Chronic Lymhocytic Leukemia; Rheumatoid Arthritis; Others

2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy; Other Direct Distribution Channels

3) By Route Of Administration: Subcutaneous; Intravenous; Molecular Type

Companies Mentioned:Pfizer Inc.; Mylan Inc.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Celltrion Healthcare Co.,Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: h1163

Table of Contents

1. Executive Summary

2. Rituximab Biosimilars Market Characteristics

3. Rituximab Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Rituximab Biosimilars

5. Rituximab Biosimilars Market Size And Growth

  • 5.1. Global Rituximab Biosimilars Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Rituximab Biosimilars Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Rituximab Biosimilars Market Segmentation

  • 6.1. Global Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Non-Hodgkin's lymphoma
  • Chronic Lymhocytic Leukemia
  • Rheumatoid arthritis
  • Others
  • 6.2. Global Rituximab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Other Direct Distribution Channels
  • 6.3. Global Rituximab Biosimilars Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Subcutaneous
  • Intravenous
  • Molecular Type

7. Rituximab Biosimilars Market Regional And Country Analysis

  • 7.1. Global Rituximab Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Rituximab Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Rituximab Biosimilars Market

  • 8.1. Asia-Pacific Rituximab Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Rituximab Biosimilars Market

  • 9.1. China Rituximab Biosimilars Market Overview
  • 9.2. China Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Rituximab Biosimilars Market

  • 10.1. India Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Rituximab Biosimilars Market

  • 11.1. Japan Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Rituximab Biosimilars Market

  • 12.1. Australia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Rituximab Biosimilars Market

  • 13.1. Indonesia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Rituximab Biosimilars Market

  • 14.1. South Korea Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Rituximab Biosimilars Market

  • 15.1. Western Europe Rituximab Biosimilars Market Overview
  • 15.2. Western Europe Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Rituximab Biosimilars Market

  • 16.1. UK Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Rituximab Biosimilars Market

  • 17.1. Germany Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Rituximab Biosimilars Market

  • 18.3. France Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Rituximab Biosimilars Market

  • 19.1. Eastern Europe Rituximab Biosimilars Market Overview
  • 19.2. Eastern Europe Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Rituximab Biosimilars Market

  • 20.1. Russia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Rituximab Biosimilars Market

  • 21.1. North America Rituximab Biosimilars Market Overview
  • 21.2. North America Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Rituximab Biosimilars Market

  • 22.1. USA Rituximab Biosimilars Market Overview
  • 22.2. USA Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Rituximab Biosimilars Market

  • 23.1. South America Rituximab Biosimilars Market Overview
  • 23.2. South America Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Rituximab Biosimilars Market

  • 24.1. Brazil Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Rituximab Biosimilars Market

  • 25.1. Middle East Rituximab Biosimilars Market Overview
  • 25.2. Middle East Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Rituximab Biosimilars Market

  • 26.1. Africa Rituximab Biosimilars Market Overview
  • 26.2. Africa Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Rituximab Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Rituximab Biosimilars Market Competitive Landscape
  • 27.2. Rituximab Biosimilars Market Company Profiles
    • 27.2.1. Pfizer Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Mylan Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Amgen Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Teva Pharmaceutical Industries Ltd.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Celltrion Healthcare Co.,Ltd.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Rituximab Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Rituximab Biosimilars Market

30. Rituximab Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer